Agios Pharmaceuticals reported $8.49M in Stock for its fiscal quarter ending in December of 2022.

Stock Change Date
Agios Pharmaceuticals USD 8.49M 3.32M Dec/2022
Arrowhead Research USD 0 0 Mar/2022
AstraZeneca USD 3.68B 121M Sep/2020
Bayer EUR 12.79B 1.42B Sep/2022
BioMarin Pharmaceutical USD 894.08M 54.62M Dec/2022
Eli Lilly USD 4.31B 478.6M Dec/2022
Gilead Sciences USD 3.37B 1.7B Dec/2023
GlaxoSmithKline GBP 5.15B 487M Dec/2022
Merck USD 5.91B 297M Dec/2022
Novartis USD 7.18B 396M Dec/2022
Novartis USD 6.67B 465M Dec/2021
Pfizer USD 8.98B 532M Dec/2022
Roche Holding CHF 8.6B 313M Dec/2022